Siemens and BioNTech expand their collaboration for global vaccine production
Joint creation of a vaccine production facility in Singapore
24-Jun-2021 -
German biotechnology company BioNTech SE, based in Mainz, and Siemens intend to expand their strategic cooperation. The companies plan to intensify their collaboration for the rapid expansion and creation of production capacity for the Covid-19 vaccine. BioNTech has expressed its aim of ...
BioNTech
biopharmaceutical manufacturing
coronaviruses
+4